Home › Funds › SECTOR GAMMA AS › DNLI
SECTOR GAMMA AS position in DNLI
DENALI THERAPEUTICS INC · Health Care
SECTOR GAMMA AS reported holding 137,718 shares of DNLI (DENALI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.8M, representing 0.59% of its reported portfolio and ranking #39 among its reported holdings. SECTOR GAMMA AS has disclosed DNLI holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SECTOR GAMMA AS's DNLI position evolved
SECTOR GAMMA AS first disclosed a stake in DNLI in Q1 2026 at 162,710 shares (US$3.1M). Across 2 filings, SECTOR GAMMA AS held the position steady without any share-count change. The most recent filing (Q3 2026) shows 137,718 shares valued at US$2.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 162.71K | $3.12M | New |
| Q3 2026 | 137.72K | $2.85M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DNLI and 13F data
DNLI (DENALI THERAPEUTICS INC) is a Health Care company. 40 other funds we track also report a position in DNLI — the largest reported positions include Temasek Holdings (US$180.4M), Temasek Holdings (Private) Ltd (US$145.0M), BAKER BROS. ADVISORS LP (US$96.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNLI
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Temasek Holdings (Private) Ltd 7.01M sh · $144.96M · Q3 2026
- BAKER BROS. ADVISORS LP 3.73M sh · $96.05M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Crestline Management, L.P. 1.91M sh · $49.14M · Q2 2026
- Foresite Capital Management VI LLC 1.40M sh · $35.92M · Q2 2026
- Siren, L.L.C. 1.40M sh · $28.87M · Q3 2026
- ADAR1 Capital Management, LLC 1.03M sh · $26.47M · Q2 2026
More on SECTOR GAMMA AS
FAQ
How long has SECTOR GAMMA AS held DNLI?
SECTOR GAMMA AS has disclosed DNLI holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is SECTOR GAMMA AS's current position in DNLI?
As of Q3 2026, SECTOR GAMMA AS holds 137.72K shares of DNLI (DENALI THERAPEUTICS INC), valued at $2.85M, representing 0.59% of its reported portfolio and ranking #39.
Has SECTOR GAMMA AS been buying or selling DNLI?
In the latest 13F filing (Q3 2026), SECTOR GAMMA AS newly opened its position in DNLI.
Which other funds hold DNLI?
Other major institutional holders of DNLI include Temasek Holdings, Temasek Holdings (Private) Ltd, BAKER BROS. ADVISORS LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.